Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome

被引：0
|
作者：
Shuichi Ito
Koichi Kamei
Masao Ogura
Tomohiro Udagawa
Shuichiro Fujinaga
Mari Saito
Mayumi Sako
Kazumoto Iijima
机构：
[1] National Center for Child Health and Development,Division of Pediatric Nephrology and Rheumatology
[2] Saitama Children’s Medical Center,Division of Nephrology
[3] National Center for Child Health and Development,Clinical Research Center
[4] Kobe University Graduate School of Medicine,Division of Child Health & Development, Department of Pediatrics
[5] National Center for Child Health and Development,Division of Nephrology and Rheumatology
来源：
Pediatric Nephrology | 2013年 / 28卷
关键词：
Rituximab; Nephrotic syndrome; Children; Steroid; Steroid-dependent nephrotic syndrome; Steroid-resistant nephrotic syndrome; Immunosuppressive agents;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：257 / 264
页数：7
相关论文
共 50 条
  • [1] Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome
    Ito, Shuichi
    Kamei, Koichi
    Ogura, Masao
    Udagawa, Tomohiro
    Fujinaga, Shuichiro
    Saito, Mari
    Sako, Mayumi
    Iijima, Kazumoto
    PEDIATRIC NEPHROLOGY, 2013, 28 (02) : 257 - 264
  • [2] Rituximab for childhood-onset nephrotic syndrome
    Hodson, Elisabeth M.
    Craig, Jonathan C.
    LANCET, 2014, 384 (9950) : 1242 - 1243
  • [3] Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome
    Koichi Kamei
    Masao Ogura
    Mai Sato
    Shuichi Ito
    Kenji Ishikura
    Pediatric Nephrology, 2018, 33 : 1013 - 1018
  • [4] Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome
    Kamei, Koichi
    Ogura, Masao
    Sato, Mai
    Ito, Shuichi
    Ishikura, Kenji
    PEDIATRIC NEPHROLOGY, 2018, 33 (06) : 1013 - 1018
  • [5] Rituximab for childhood refractory nephrotic syndrome
    Iijima, Kazumoto
    PEDIATRICS INTERNATIONAL, 2011, 53 (05) : 617 - 621
  • [6] CD4+and CD8+T-lymphocyte number as predictive marker of relapse after rituximab treatment in childhood-onset refractory nephrotic syndrome
    Kanamori, Toru
    Kamei, Koichi
    Sato, Mai
    Nishi, Kentaro
    Okutsu, Mika
    Ishiwa, Sho
    Ogura, Masao
    Sako, Mayumi
    Ishikura, Kenji
    Ito, Shuichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (07) : 622 - 630
  • [7] Management patterns of childhood-onset nephrotic syndrome
    MacHardy, Nathaniel
    Miles, Paul V.
    Massengill, Susan F.
    Smoyer, William E.
    Mahan, John D.
    Greenbaum, Larry
    Massie, Sara
    Yao, Lynne
    Nagaraj, Shashi
    Lin, Jen-Jar
    Wigfall, Delbert
    Trachtman, Howard
    Hu, Yichun
    Gipson, Debbie S.
    PEDIATRIC NEPHROLOGY, 2009, 24 (11) : 2193 - 2201
  • [8] Rituximab for refractory cases of childhood nephrotic syndrome
    Kari, Jameela A.
    El-Morshedy, Salah M.
    El-Desoky, Sherif
    Alshaya, Hammad O.
    Rahim, Khawla A.
    Edrees, Burhan M.
    PEDIATRIC NEPHROLOGY, 2011, 26 (05) : 733 - 737
  • [9] CD4 + and CD8 + T-lymphocyte number as predictive marker of relapse after rituximab treatment in childhood-onset refractory nephrotic syndrome
    Toru Kanamori
    Koichi Kamei
    Mai Sato
    Kentaro Nishi
    Mika Okutsu
    Sho Ishiwa
    Masao Ogura
    Mayumi Sako
    Kenji Ishikura
    Shuichi Ito
    Clinical and Experimental Nephrology, 2023, 27 : 622 - 630
  • [10] Real-word adrenocorticotropic hormone treatment for childhood-onset nephrotic syndrome
    Wang, Ying
    Dang, Xiqiang
    Wu, Xiaochuan
    Li, Yongzhen
    He, Qingnan
    Li, Xiaoyan
    FRONTIERS IN PEDIATRICS, 2023, 11
12345